ORIC Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Update Portfolio News / By Karina Tin November 8, 2021 ORIC Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Update Read More »
Neurona Therapeutics Presents Preclinical Data from Lead Cell Therapy Candidate NRTX-1001 at Neuroscience 2021 Portfolio News / By Karina Tin November 8, 2021 Neurona Therapeutics Presents Preclinical Data from Lead Cell Therapy Candidate NRTX-1001 at Neuroscience 2021 Read More »
NGM Bio Provides Business Highlights and Reports Third Quarter 2021 Financial Results Portfolio News / By Karina Tin November 4, 2021 NGM Bio Provides Business Highlights and Reports Third Quarter 2021 Financial Results Read More »
ORIC Pharmaceuticals to Present Update on CD73 Inhibitor Program in Multiple Myeloma at the American Society of Hematology (ASH) Annual Meeting Portfolio News / By Karina Tin November 4, 2021 ORIC Pharmaceuticals to Present Update on CD73 Inhibitor Program in Multiple Myeloma at the American Society of Hematology (ASH) Annual Meeting Read More »
Neurona Therapeutics Receives IND Clearance to Initiate Phase 1/2 Clinical Trial of Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients Portfolio News / By Karina Tin November 4, 2021 Neurona Therapeutics Receives IND Clearance to Initiate Phase 1/2 Clinical Trial of Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients Read More »
Plexium Appoints Percival Barretto-Ko as President and Chief Executive Officer Portfolio News / By Karina Tin November 4, 2021 Plexium Appoints Percival Barretto-Ko as President and Chief Executive Officer Read More »
Synthekine Establishes Collaboration with Merck to Develop Therapeutic Candidates Using its Proprietary Surrogate Cytokine Agonist Platform Portfolio News / By Karina Tin November 1, 2021 Synthekine Establishes Collaboration with Merck to Develop Therapeutic Candidates Using its Proprietary Surrogate Cytokine Agonist Platform Read More »
